D. E. Shaw & Co., Inc. Atri Cure, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Atri Cure, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 117,296 shares of ATRC stock, worth $3.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

117,296

Holding current value

$3.55 Million

% of portfolio

0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$20.34 - $29.5 $238,201 - $345,474	11,711 Added 11.09%	117,296 $3.29 Million
Q2 2024 Aug 14, 2024	SELL	$19.86 - $29.09 $985,254 - $1.44 Million	-49,610 Reduced 31.97%	105,585 $2.4 Million
Q1 2024 May 15, 2024	BUY	$28.21 - $37.78 $1.3 Million - $1.74 Million	46,179 Added 42.36%	155,195 $4.72 Million
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $1.23 Million - $1.61 Million	37,266 Added 51.94%	109,016 $3.89 Million
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $3.3 Million - $4.63 Million	-80,249 Reduced 52.8%	71,750 $3.14 Million
Q2 2023 Aug 14, 2023	SELL	$40.44 - $49.6 $1.08 Million - $1.33 Million	-26,828 Reduced 15.0%	151,999 $7.5 Million
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $2.25 Million - $2.96 Million	62,764 Added 54.08%	178,827 $7.41 Million
Q4 2022 Feb 14, 2023	SELL	$33.48 - $47.45 $2.59 Million - $3.67 Million	-77,394 Reduced 40.01%	116,063 $5.15 Million
Q3 2022 Nov 14, 2022	SELL	$38.25 - $52.62 $785,387 - $1.08 Million	-20,533 Reduced 9.6%	193,457 $7.57 Million
Q2 2022 Aug 15, 2022	BUY	$35.1 - $66.01 $4.19 Million - $7.88 Million	119,314 Added 126.02%	213,990 $8.74 Million
Q1 2022 May 16, 2022	BUY	$57.43 - $71.39 $3 Million - $3.73 Million	52,251 Added 123.16%	94,676 $6.22 Million
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $803,721 - $1.1 Million	12,677 Added 42.61%	42,425 $2.95 Million
Q3 2021 Nov 15, 2021	BUY	$69.28 - $84.46 $528,467 - $644,260	7,628 Added 34.48%	29,748 $2.07 Million
Q2 2021 Aug 16, 2021	SELL	$64.13 - $80.18 $845,233 - $1.06 Million	-13,180 Reduced 37.34%	22,120 $1.76 Million
Q1 2021 May 17, 2021	SELL	$53.79 - $66.98 $5.15 Million - $6.41 Million	-95,773 Reduced 73.07%	35,300 $2.31 Million
Q4 2020 Feb 16, 2021	SELL	$34.56 - $57.55 $4.17 Million - $6.95 Million	-120,741 Reduced 47.95%	131,073 $7.3 Million
Q3 2020 Nov 16, 2020	SELL	$38.36 - $46.91 $4.85 Million - $5.94 Million	-126,540 Reduced 33.44%	251,814 $10 Million
Q2 2020 Aug 14, 2020	BUY	$31.78 - $51.19 $6.36 Million - $10.2 Million	200,021 Added 112.16%	378,354 $17 Million
Q1 2020 May 15, 2020	BUY	$24.49 - $43.84 $1.43 Million - $2.57 Million	58,564 Added 48.9%	178,333 $5.99 Million
Q4 2019 Feb 14, 2020	BUY	$24.06 - $32.51 $440,153 - $594,737	18,294 Added 18.03%	119,769 $3.89 Million
Q3 2019 Nov 14, 2019	SELL	$23.81 - $32.52 $2.1 Million - $2.87 Million	-88,278 Reduced 46.52%	101,475 $2.53 Million
Q2 2019 Aug 14, 2019	SELL	$26.85 - $30.74 $2.97 Million - $3.4 Million	-110,456 Reduced 36.79%	189,753 $5.66 Million
Q1 2019 May 15, 2019	BUY	$26.38 - $33.34 $772,775 - $976,661	29,294 Added 10.81%	300,209 $8.04 Million
Q4 2018 Feb 14, 2019	BUY	$26.66 - $34.85 $2.56 Million - $3.35 Million	96,176 Added 55.04%	270,915 $8.29 Million
Q3 2018 Nov 14, 2018	SELL	$27.62 - $35.58 $1.09 Million - $1.41 Million	-39,559 Reduced 18.46%	174,739 $6.12 Million
Q2 2018 Aug 14, 2018	BUY	$19.65 - $30.28 $417,071 - $642,693	21,225 Added 10.99%	214,298 $5.8 Million
Q1 2018 May 15, 2018	BUY	$15.05 - $21.03 $595,167 - $831,652	39,546 Added 25.76%	193,073 $3.96 Million
Q4 2017 Feb 14, 2018	BUY	$17.69 - $23.44 $740,220 - $980,823	41,844 Added 37.47%	153,527 $2.8 Million
Q3 2017 Nov 14, 2017	BUY	$20.0 - $24.23 $2.23 Million - $2.71 Million	111,683	111,683 $2.5 Million

Others Institutions Holding ATRC

# of Institutions

212

Shares Held

49.7M

Call Options Held

12K

Put Options Held

7.2K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.4B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account